Annual Report

Overview

The report describes Vivoryon's 2020 conversion from an AG into a Dutch N.V. and the start of its European VIVIAD Phase 2b Alzheimer's program. It also highlights the acquisition of Meprin protease inhibitor patents and a research collaboration with Fraunhofer IZI. At year-end, the company reported 18 employees, while it had not yet generated product-candidate revenues.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2020
Period: Ends 31 December 2020
Publication date: 29 April 2021
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services